US14167L1035 - Common Stock
CAREDX INC
NASDAQ:CDNA (10/31/2024, 5:53:53 PM)
After market: 22.13 0 (0%)22.13
-0.85 (-3.7%)
CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. The company is headquartered in Brisbane California, California and currently employs 635 full-time employees. The company went IPO on 2014-07-17. The firm is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The firm offers testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. Its commercially available testing services consist of AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The Company’s product portfolio includes AlloSeq Tx, QTYPE, Olerup SSP, AlloSeq HCT and AlloSeq cfDNA. The company develops and provides diagnostic surveillance testing services for various transplant recipients.
CAREDX INC
8000 Marina Blvd, 4th Floor
Brisbane California CALIFORNIA 94080
P: 14152872300
CEO: Reginald Seeto
Employees: 635
Website: https://www.caredx.com/
In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down.
Get insights into the top gainers and losers of Tuesday's pre-market session.
Here you can normally see the latest stock twits on CDNA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: